Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114851514 | 11485151 | 4 | F | 20150811 | 20160729 | 20150909 | 20160805 | EXP | JP-GSKJP-JP2015JPN118611AA | GLAXOSMITHKLINE | 87.44 | YR | F | Y | 52.00000 | KG | 20160805 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114851514 | 11485151 | 1 | PS | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 1500 MG, 1D | 1500 | MG | Y | 20487 | 1500 | MG | TABLET | QD | |||
| 114851514 | 11485151 | 2 | SS | FAMVIR | FAMCICLOVIR | 1 | Oral | 1500 MG, 1D | 6000 | MG | 0 | 1500 | MG | QD | |||||
| 114851514 | 11485151 | 3 | C | VIDARABINE | VIDARABINE | 1 | UNK | 0 | |||||||||||
| 114851514 | 11485151 | 4 | C | PARIET | RABEPRAZOLE SODIUM | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 114851514 | 11485151 | 5 | C | JUVELA N | TOCOPHERYL NICOTINATE, D-.ALPHA. | 1 | 200 MG, BID | 0 | 100 | MG | BID | ||||||||
| 114851514 | 11485151 | 6 | C | EPADEL S | ICOSAPENT ETHYL | 1 | 900 MG, BID | 0 | 900 | MG | BID | ||||||||
| 114851514 | 11485151 | 7 | C | MAGLAX | MAGNESIUM OXIDE | 1 | 500 MG, BID | 0 | 500 | MG | BID | ||||||||
| 114851514 | 11485151 | 8 | C | BAYASPIRIN | ASPIRIN | 1 | 100 MG, QD | 0 | 100 | MG | QD | ||||||||
| 114851514 | 11485151 | 9 | C | AZILVA | AZILSARTAN KAMEDOXOMIL | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 114851514 | 11485151 | 10 | C | AMLODIN OD | AMLODIPINE BESYLATE | 1 | 5 MG, QD | 0 | 5 | MG | QD | ||||||||
| 114851514 | 11485151 | 11 | C | LENDORMIN D | BROTIZOLAM | 1 | 0.25 MG, QD | 0 | .25 | MG | QD | ||||||||
| 114851514 | 11485151 | 12 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | 5 MG, BID | 0 | 5 | MG | BID | ||||||||
| 114851514 | 11485151 | 13 | C | METHYCOBAL | METHYLCOBALAMIN | 1 | 1.5 MG, 1D | 0 | 1.5 | MG | QD | ||||||||
| 114851514 | 11485151 | 14 | C | LOXOPROFEN SODIUM HYDRATE | LOXOPROFEN SODIUM DIHYDRATE | 1 | 180 MG, 1D | 0 | 180 | MG | QD | ||||||||
| 114851514 | 11485151 | 15 | C | UNKNOWN DRUG | UNSPECIFIED INGREDIENT | 1 | 150 MG, 1D | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114851514 | 11485151 | 1 | Herpes zoster |
| 114851514 | 11485151 | 2 | Herpes zoster |
| 114851514 | 11485151 | 15 | Herpes zoster |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114851514 | 11485151 | HO |
| 114851514 | 11485151 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114851514 | 11485151 | Acute kidney injury | |
| 114851514 | 11485151 | Altered state of consciousness | |
| 114851514 | 11485151 | Aortic aneurysm | |
| 114851514 | 11485151 | Dysarthria | |
| 114851514 | 11485151 | Gait disturbance | |
| 114851514 | 11485151 | Mental disorder | |
| 114851514 | 11485151 | Toxic encephalopathy | |
| 114851514 | 11485151 | Urine output decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114851514 | 11485151 | 1 | 20150810 | 20150811 | 0 | |
| 114851514 | 11485151 | 2 | 20150805 | 20150809 | 0 |